company background image
P8A logo

Cordlife Group SGX:P8A Stock Report

Last Price

S$0.15

Market Cap

S$37.7m

7D

0%

1Y

-73.3%

Updated

15 Jul, 2024

Data

Company Financials

P8A Stock Overview

An investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally.

P8A fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends0/6

Cordlife Group Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cordlife Group
Historical stock prices
Current Share PriceS$0.15
52 Week HighS$0.56
52 Week LowS$0.12
Beta0.68
11 Month Change-3.29%
3 Month Change-0.68%
1 Year Change-73.27%
33 Year Change-62.78%
5 Year Change-73.51%
Change since IPO-78.38%

Recent News & Updates

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

May 06
Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Recent updates

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

May 06
Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

Mar 22
Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

Sep 07
Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

Aug 02
Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Apr 03
Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Oct 15
Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Aug 22
Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Shareholder Returns

P8ASG HealthcareSG Market
7D0%2.7%2.5%
1Y-73.3%-19.2%2.2%

Return vs Industry: P8A underperformed the SG Healthcare industry which returned -19.2% over the past year.

Return vs Market: P8A underperformed the SG Market which returned 2.2% over the past year.

Price Volatility

Is P8A's price volatile compared to industry and market?
P8A volatility
P8A Average Weekly Movement11.9%
Healthcare Industry Average Movement4.9%
Market Average Movement4.7%
10% most volatile stocks in SG Market13.2%
10% least volatile stocks in SG Market2.1%

Stable Share Price: P8A has not had significant price volatility in the past 3 months.

Volatility Over Time: P8A's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of SG stocks.

About the Company

FoundedEmployeesCEOWebsite
2001n/aIvan Yiuwww.cordlife.com

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It offers cord blood, cord lining, and cord tissue banking services, including processing and storage of stem cells; and various diagnostics services, such as newborn genetic screening, pediatric vision and ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing, and newborn metabolic screening.

Cordlife Group Limited Fundamentals Summary

How do Cordlife Group's earnings and revenue compare to its market cap?
P8A fundamental statistics
Market capS$37.68m
Earnings (TTM)S$3.52m
Revenue (TTM)S$55.73m

10.7x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
P8A income statement (TTM)
RevenueS$55.73m
Cost of RevenueS$18.43m
Gross ProfitS$37.31m
Other ExpensesS$33.78m
EarningsS$3.52m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.014
Gross Margin66.94%
Net Profit Margin6.32%
Debt/Equity Ratio0%

How did P8A perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.